Literature DB >> 3317064

Tumour necrosis factor. Another chapter in the long history of endotoxin.

L J Old1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3317064     DOI： 10.1038/330602a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Identification of an immunoreactive non-proteinaleous component in Borrelia burgdorferi.

Authors:  H Eiffert; H Lotter; K Jarecki-Khan; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

2.  The endogenous induction of tumor necrosis factor serum (TNS) for the adjuvant postoperative immunotherapy of cancer--changes in immunological markers of the blood.

Authors:  Y Abe; M Miyake; T Miyazaki; A Horiuchi; S Kimura
Journal:  Jpn J Surg       Date:  1990-01

Review 3.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

Review 4.  The roles of exercise-induced immune system disturbances in the pathology of heat stroke : the dual pathway model of heat stroke.

Authors:  Chin Leong Lim; Laurel T Mackinnon
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

5.  Growth-inhibiting effect of intratumoral recombinant human tumor necrosis factor on an experimental model of primitive neuroectodermal tumor.

Authors:  J Vaquero; M Zurita; S Oya
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 6.  The role of tumor necrosis factor receptors in cell signaling and the significance of soluble form levels in the serum.

Authors:  Y Abe; Y Watanabe; S Kimura
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 7.  Gut-liver axis and sterile signals in the development of alcoholic liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Alcohol Alcohol       Date:  2017-07-01       Impact factor: 2.826

8.  Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.

Authors:  G Rowlinson-Busza; A Maraveyas; A A Epenetos
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.